Cancer Center Amsterdam
-
Impact of hemodilution on flow cytometry based measurable residual disease assessment in acute myeloid leukemia
Tettero, J. M., Heidinga, M. E., Mocking, T. R., Fransen, G., Kelder, A., Scholten, W. J., Snel, A. N., Ngai, L. L., Bachas, C., van de Loosdrecht, A. A., Ossenkoppele, G. J., de Leeuw, D. C., Cloos, J. & Janssen, J. J. W. M., Mar 2024, In: Leukemia. 38, 3, p. 630-639 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML
Tettero, J. M., Buisman, Y., Ngai, L. L., Bachas, C., Gjertsen, B. T., Kelder, A., van de Loosdrecht, A. A., Manz, M. G., Pabst, T., Scholten, W., Ossenkoppele, G. J., Cloos, J. & de Leeuw, D. C., 21 Dec 2023, In: HemaSphere. 7, 12, p. E981Research output: Contribution to journal › Article › Academic › peer-review
-
Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometry
Tettero, J. M., Dakappagari, N., Heidinga, M. E., Oussoren-Brockhoff, Y., Hanekamp, D., Pahuja, A., Burns, K., Kaur, P., Alfonso, Z., van der Velden, V. H. J., te Marvelde, J. G., Hobo, W., Slomp, J., Bachas, C., Kelder, A., Nguyen, K. & Cloos, J., Nov 2023, In: Cytometry Part B - Clinical Cytometry. 104, 6, p. 426-439 14 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications